The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years

MLA

Pål Aukrust, et al. “The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years.” The Journal of Heart and Lung Transplantation, vol. 34, Apr. 2015, p. S32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d106710347bc42c7e19aa055fe6629d0&authtype=sso&custid=ns315887.

APA

Pål Aukrust, D. Solbu, Lars Gullestad, Kristjan Karason, Finn Gustafsson, Hans Erik Bøtker, H. Eisjær, Satish Arora, Thor Ueland, Göran Rådegran, Kari Saunamäki, Lars Aaberge, & Einar Gude. (2015). The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years. The Journal of Heart and Lung Transplantation, 34, S32.

Chicago

Pål Aukrust, D. Solbu, Lars Gullestad, Kristjan Karason, Finn Gustafsson, Hans Erik Bøtker, H. Eisjær, et al. 2015. “The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years.” The Journal of Heart and Lung Transplantation 34 (April): S32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d106710347bc42c7e19aa055fe6629d0&authtype=sso&custid=ns315887.